CV event risk lower in women vs. men after non-ST segment elevation ACS
Women who were enrolled in clinical trials had a lower risk for major adverse CV events compared with men after non-ST segment elevation ACS, according to a sex-specific analysis published in the Journal of the American College of Cardiology. Researchers also found that women were undertreated compared with men.